Amsterdam, The Netherlands - 18 June 2018
Esperite regrets to announce that due remaining technical issues as reported before and despite the constant efforts provided by the different teams involved, additional time is needed for the Company to publish its Annual Report 2017.
Esperite will issue the Annual Report as soon as possible.
About ESPERITE
ESPERITE group, listed at Euronext Amsterdam and Paris, is a leading international company in regenerative and precision medicine founded in 2000.
To learn more about the ESPERITE Group, or to book an interview with CEO Frédéric Amar: +31 575 548 998 - ir@esperite.com or visit the websites at www.esperite.com, www.genoma.com and www.cryo-save.com.
***
This press release contains inside information as referred to in article 7 paragraph 1 of Regulation (EU) 596/2014 (Market Abuse Regulation).
